Back to BLTE

UBS Group AG → BLTE

UBS Group AG BLTE Position History

Belite Bio, Inc • Healthcare

Quarters held
12
Latest value
$17K
Q3 2026
Peak value
$113.9M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$303K
Q3 2025$536K
Q4 2025$15.1M
Q4 2025$5.5M
Q4 2025$24K
Q1 2026$113.9M
Q1 2026$8.2M
Q1 2026$398K
Q2 2026$34.6M
Q2 2026$17K
Q3 2026$26.9M
Q3 2026$17K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$17K100——
Q3 2026$26.9M158.3K——
Q2 2026$17K113——
Q2 2026$34.6M224.9K——
Q1 2026$398K2.5K——
Q1 2026$8.2M51.7K——
Q1 2026$113.9M714.2K——
Q4 2025$24K153——
Q4 2025$5.5M34.5K——
Q4 2025$15.1M94.1K——
Q3 2025$536K7.2K——
Q3 2025$303K4.1K——

Other funds holding BLTE

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B